Literature DB >> 18577469

The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial and Hurricane Katrina: lessons for managing clinical trials during and after a natural disaster.

Roberta McDuffie1, John Summerson, Patricia Reilly, Caroline Blackwell, David Goff, Angela R Kimel, Lenore Crago, Vivian Fonseca.   

Abstract

Hurricane Katrina was one of the most catastrophic natural disasters to hit the United States. It had a major impact on health care in New Orleans, LA and the surrounding region, not only in relation to acute illness but also chronic disease. When Hurricane Katrina struck New Orleans on August 29, 2005, there were 193 participants being followed in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial at Tulane University Health Sciences Center. In the immediate aftermath of the storm, the Tulane University ACCORD Study site, in collaboration with the Study Coordinating Center and the Southeast Clinical Center Network office of the trial at Wake Forest University Health Sciences in North Carolina, took several actions in order to locate the participants, ensure their safety, and maintain the scientific integrity of the trial. We describe the actions taken and the relative success/failure of such actions.

Entities:  

Mesh:

Year:  2008        PMID: 18577469      PMCID: PMC2607140          DOI: 10.1016/j.cct.2008.05.006

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  8 in total

1.  The Hurricane Katrina aftermath and its impact on diabetes care: observations from "ground zero": lessons in disaster preparedness of people with diabetes.

Authors:  William T Cefalu; Steven R Smith; Lawrence Blonde; Vivian Fonseca
Journal:  Diabetes Care       Date:  2006-01       Impact factor: 19.112

2.  After the storm--health care infrastructure in post-Katrina New Orleans.

Authors:  Ruth E Berggren; Tyler J Curiel
Journal:  N Engl J Med       Date:  2006-04-13       Impact factor: 91.245

3.  Lessons from Hurricane Rita: organizing to provide medical care during a natural disaster.

Authors:  Thomas J Walsh; Susan Orsega; David Banks
Journal:  Ann Intern Med       Date:  2006-08-14       Impact factor: 25.391

4.  Personal observations and lessons from Katrina.

Authors:  L Lee Hamm
Journal:  Am J Med Sci       Date:  2006-11       Impact factor: 2.378

5.  American Diabetes Association Statement on Emergency and Disaster Preparedness: a report of the Disaster Response Task Force.

Authors: 
Journal:  Diabetes Care       Date:  2007-07-10       Impact factor: 19.112

6.  Effect of the Kobe earthquake on stress and glycemic control in patients with diabetes mellitus.

Authors:  A Inui; H Kitaoka; M Majima; S Takamiya; M Uemoto; C Yonenaga; M Honda; K Shirakawa; N Ueno; K Amano; S Morita; A Kawara; K Yokono; M Kasuga; H Taniguchi
Journal:  Arch Intern Med       Date:  1998-02-09

7.  Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.

Authors:  John B Buse; J Thomas Bigger; Robert P Byington; Lawton S Cooper; William C Cushman; William T Friedewald; Saul Genuth; Hertzel C Gerstein; Henry N Ginsberg; David C Goff; Richard H Grimm; Karen L Margolis; Jeffrey L Probstfield; Denise G Simons-Morton; Mark D Sullivan
Journal:  Am J Cardiol       Date:  2007-04-16       Impact factor: 2.778

8.  Chronic disease in health emergencies: in the eye of the hurricane.

Authors:  Earl S Ford; Ali H Mokdad; Michael W Link; William S Garvin; Lisa C McGuire; Ruth B Jiles; Lina S Balluz
Journal:  Prev Chronic Dis       Date:  2006-03-15       Impact factor: 2.830

  8 in total
  3 in total

1.  Challenges in early phase clinical trials for childhood cancer during the COVID-19 pandemic: a report from the new agents group of the Spanish Society of Paediatric Haematology and Oncology (SEHOP).

Authors:  A Rubio-San-Simón; J Verdú-Amorós; R Hladun; A Juan-Ribelles; M Molero; P Guerra-García; A Pérez-Martínez; A Castañeda; A Cañete; T de Rojas; L Moreno; F Bautista
Journal:  Clin Transl Oncol       Date:  2020-05-29       Impact factor: 3.405

2.  Mitigating the impact of disasters and emergencies on clinical trials site conduct: A site perspective following major and minor unforeseen events.

Authors:  Helen Lunt; Helen Heenan
Journal:  Contemp Clin Trials Commun       Date:  2019-11-12

3.  Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium.

Authors:  Alba Rubio-San-Simón; Nicolas André; Maria Giuseppina Cefalo; Isabelle Aerts; Alicia Castañeda; Sarah Benezech; Guy Makin; Natasha van Eijkelenburg; Karsten Nysom; Lynley Marshall; Marion Gambart; Raquel Hladun; Claudia Rossig; Luca Bergamaschi; Franca Fagioli; Ben Carpenter; Stephane Ducassou; Cormac Owens; Ingrid Øra; Antonio Juan Ribelles; Bram De Wilde; Pilar Guerra-García; Marion Strullu; Carmelo Rizzari; Torben Ek; Simone Hettmer; Nicolas U Gerber; Christine Rawlings; Manuel Diezi; Sauli Palmu; Antonio Ruggiero; Jaime Verdú; Teresa de Rojas; Gilles Vassal; Birgit Geoerger; Lucas Moreno; Francisco Bautista
Journal:  Eur J Cancer       Date:  2020-10-09       Impact factor: 9.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.